Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study

Wang, Chenran; Liu, Mi; Chen, Zhe; Liu, Shiwei

doi:10.1186/s12872-020-01530-0

Cited by 16 publications

(7 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of deaths and mortality of males with IHD were higher than those of females, consistent with the results of multiple studies[ 3 , 13 , 28 , 29 ], suggesting that male residents are more affected by IHD than female residents. In addition, male deaths from IHD are concentrated in the middle-aged and older age groups.…”

Section: Discussionsupporting

confidence: 90%

“…The number of deaths and mortality of males with IHD were higher than those of females, consistent with Fig. 4 Trend of mortality of IHD from 2010 to 2019 by sex and age (1/100,000) 10-24: a) total: APC = − 4.25% * , e) male: APC = − 4.07% * , i) female: APC = − 4.88% * 25-49: b) total: APC = 0.15%, f ) male: APC = 0.85% * , j) female: APC = − 1.96% * 50-74: c) total: APC = 1.37%, g) male: APC = 1.81% * , k) female: APC = 0.70% ≥ 75: d) total: APC = 1.88% * , h) male: APC = 1.19%, l) female: APC = 2.43% * Note: * The estimated regression model had statistical significance the results of multiple studies [3,13,28,29], suggesting that male residents are more affected by IHD than female residents. In addition, male deaths from IHD are concentrated in the middle-aged and older age groups.…”

Section: Discussionmentioning

confidence: 95%

See 1 more Smart Citation

Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis

Wang

Jiang

et al. 2023

BMC Public Health

View full text Add to dashboard Cite

Background This study presented the mortality trend of ischemic heart disease (IHD) in Chinese residents from 2010 to 2019 and provided a basis for further establishment of relevant interventions. Methods Data, such as sex, age, urban and rural areas, and death status, were extracted from the China Death Surveillance Dataset from 2010 to 2019, with mortality and age-adjusted death rates (AADRs) as the main indicators. The joinpoint regression model was used to analyze mortality and AADRs trends in IHD. A semi-structured expert interview was conducted to propose targeted intervention measures and countermeasures. Results We observed an overall upward trend in IHD mortality rates and AADRs in China from 2010 to 2019 (average annual percentage change [AAPC] = 5.14%, AAPCAADRs = 1.60%, P < 0.001). Mortality rates and AADRs increased for both males (AAPC = 4.91%, AAPCAADRs = 1.09%, P < 0.05) and females (AAPC = 5.57%, AAPCAADRs = 1.84%, P < 0.001), with higher mortality rate for males than females but higher variation for females than males. Urban (AAPC = 4.80%, AAPCAADRs = 1.76%, P < 0.05) and rural (AAPC = 5.31%, P < 0.001; AAPCAADRs = 0.99%, P > 0.05) mortality rates increased, with the mortality rate higher in rural areas than in urban areas. In the age analysis, mortality rate was higher in middle-aged and older adults than in other age groups. The age-sex cross-analysis found the highest trend in mortality rates among females aged ≥ 75 years (annual percentage change [APC] = 2.43%, P < 0.05). Conclusions The upward trend in IHD mortality in China from 2010 to 2019, especially among female residents aged ≥ 75 years, poses continuing challenges to public health policies and actions.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 95%

Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis

Wang

Jiang

et al. 2023

BMC Public Health

View full text Add to dashboard Cite

show abstract

“…However, those patients who did not meet the treatment criteria or had poor compliance may have higher mortality rates (30). For NCDs, level 3 causes of lung cancer, colon and rectum cancer, pancreatic cancer, and ischemic heart disease caused the main reduction in LE and HALE due to increased mortality, as has been proved in previous studies (31)(32)(33)(34)(35). For lung cancer, more emphasis should be placed on early screening, and tobacco control, and improving air pollution by reducing industrial energy consumption and dust (36,37).…”

Section: Discussionmentioning

confidence: 81%

Changes and Trend Disparities in Life Expectancy and Health-Adjusted Life Expectancy Attributed to Disability and Mortality From 1990 to 2019 in China

Chen¹,

Wang²,

Qian³

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

ObjectiveThis study aims to investigate sex, age, and cause-specific contributions to changes and trend disparities in life expectancy (LE) and health-adjusted life expectancy (HALE) attributed to disability and mortality from 1990 to 2019 in China, which provides insight into policy-making, health systems planning, and resource allocation.MethodsContributions of disability and mortality to changes and trend disparities in LE and HALE were estimated with standard abridged life table, Sullivan's method, and decomposition method, using retrospective demographic analysis based on mortality and years lived with disability (YLD) rates extracted from Global Burden of Disease Study 2019 (GBD 2019).ResultsFrom 1990 to 2019, LE and HALE increased by 10.49 and 8.71 years for both sexes, mainly due to noncommunicable diseases (NCDs) (5.83 years, 55.58% for LE and 6.28 years, 72.10% for HALE). However, HIV/AIDS and sexually transmitted infections had negative effects on changes in LE (−0.03 years, −0.29%) and HALE (−0.05 years, −0.57%). Lung cancer and ischemic heart disease caused the biggest reduction in LE (−0.14 years, −1.33%) and HALE (−0.42 years, −4.82%). Also, cardiovascular diseases (−0.08 years, −0.92%), neurological disorders (−0.08 years, −0.92%), diabetes and kidney diseases (−0.06 years, −0.69%), and transport injuries (−0.06 years, −0.69%) had main negative disability effects in HALE. Moreover, life expectancy lived with disability (LED) increased by 1.78 years, mainly attributed to respiratory infections and tuberculosis (1.04 years, 58.43%) and maternal and neonatal disorders (0.78 years, 43.82%).ConclusionThe LE and HALE in China have grown rapidly over the past few decades, mainly attributed to NCDs. It is necessary to further reduce the negative mortality effect of HIV/AIDS, lung cancer, colon and rectum cancer, pancreatic cancer, and ischemic heart disease and the negative disability effect of stroke, diabetes mellitus, and road injuries. In addition, the signs of disparities in mortality and disability of different sexes and ages call for targeted and precise interventions for key groups such as males and the elderly. According to the decomposition results, we may better determine the key objects of health policies that take into account substantial cause-specific variations to facilitate the realization of “healthy China 2030” plan.

show abstract

“…The mortality of cardiovascular disease is increasing. In China, the annual number of deaths owing to CVD increased from 2.51 million to 3.97 million between 1990 and 2016; the prevalence rate of CVD overall increased significantly from 1990 to 2016 by 14.7% [2]. In Europe, CVD causes 49% of mortality, which is the most important cause of premature mortality and disability adjusted life years ("DALYS") in Europe.…”

Section: Introductionmentioning

confidence: 99%

Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

Chen

Tang

Yuan

et al. 2022

Oxidative Medicine and Cellular Longevity

View full text Add to dashboard Cite

Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and hypertension. Due to its high prevalence, disability, and mortality, it seriously threatens human health. According to reports, the incidence of cardiovascular disease is still on the rise. Rhodiola rosea is a kind of traditional Chinese medicine, which has the effects of antimyocardial ischemia-reperfusion injury, lowering blood fat, antithrombosis, and antiarrhythmia. Rhodiola rosea has various chemical components, and different chemical elements have the same pharmacological effects and medicinal values for various cardiovascular diseases. This article reviews the research on the pharmacological effects of Rhodiola rosea on cardiovascular diseases and provides references for the clinical treatment of cardiovascular diseases.

show abstract

Temporal and spatial trends of ischemic heart disease burden in Chinese and subgroup populations from 1990 to 2016: socio-economical data from the 2016 global burden of disease study

Cited by 16 publications

References 27 publications

Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis

Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis

Changes and Trend Disparities in Life Expectancy and Health-Adjusted Life Expectancy Attributed to Disability and Mortality From 1990 to 2019 in China

Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

Contact Info

Product

Resources

About